Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

ClinicalTrials.gov ID: NCT03706079

Public ClinicalTrials.gov record NCT03706079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre, Double-blind, Randomized, Placebo Controlled, Parallel Group, Phase 3, Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe Uncontrolled Asthma (DESTINATION)

Study identification

NCT ID
NCT03706079
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
951 participants

Conditions and interventions

Conditions

Interventions

  • Tezepelumab Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
13 Years to 81 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2019
Primary completion
Oct 25, 2021
Completion
May 17, 2022
Last update posted
Jun 5, 2023

2019 – 2022

United States locations

U.S. sites
52
U.S. states
24
U.S. cities
48
Facility City State ZIP Site status
Research Site Dothan Alabama 36303
Research Site Gilbert Arizona 85234
Research Site Bakersfield California 93301
Research Site Huntington Beach California 92647
Research Site Long Beach California 90808
Research Site Los Angeles California 90025
Research Site Newport Beach California 92663
Research Site Northridge California 91324
Research Site Palm Desert California 92260
Research Site Rolling Hills Estates California 90274
Research Site Walnut Creek California 94598
Research Site Westminster California 92683
Research Site New Haven Connecticut 06519
Research Site Kissimmee Florida 34744
Research Site Kissimmee Florida 34746
Research Site Port Charlotte Florida 33952
Research Site Sarasota Florida 34239
Research Site Tampa Florida 33607
Research Site Winter Park Florida 32789-4681
Research Site Boise Idaho 83706
Research Site Zachary Louisiana 70791
Research Site White Marsh Maryland 21162
Research Site Boston Massachusetts 02115
Research Site Ann Arbor Michigan 48109
Research Site St Louis Missouri 63141
Research Site Lincoln Nebraska 68510
Research Site Las Vegas Nevada 89119
Research Site Northfield New Jersey 08225
Research Site Brooklyn New York 11235
Research Site The Bronx New York 10459
Research Site The Bronx New York 10461
Research Site Charlotte North Carolina 28207
Research Site Durham North Carolina 27705
Research Site Winston-Salem North Carolina 27104
Research Site Cincinnati Ohio 45229
Research Site Cincinnati Ohio 45236
Research Site Edmond Oklahoma 73034
Research Site Oklahoma City Oklahoma 73120
Research Site Medford Oregon 97504
Research Site Philadelphia Pennsylvania 19140
Research Site Anderson South Carolina 29621
Research Site Columbia South Carolina 29204
Research Site Greenville South Carolina 29607
Research Site Amarillo Texas 79109
Research Site Boerne Texas 78006
Research Site McKinney Texas 75069
Research Site McKinney Texas 75071
Research Site Plano Texas 75093
Research Site San Antonio Texas 78251
Research Site Manassas Virginia 20110
Research Site Cudahy Wisconsin 53110
Research Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 128 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03706079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03706079 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →